(Q38244444)

31 August 2017

title

Reverse genetics systems as tools for the development of novel therapies against filoviruses (English)

1 reference

31 August 2017

1

1 reference

31 August 2017

2

Heinz Feldmann

1 reference

31 August 2017

publication date

28 August 2014

1 reference

Expert Review of Anti-infective Therapy

31 August 2017

published in

1 reference

31 August 2017

volume

12

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

1253-1263

1 reference

Basic clinical and laboratory features of filoviral hemorrhagic fever

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Ebola virus: unravelling pathogenesis to combat a deadly disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

The organisation of Ebola virus reveals a capacity for extensive, modular polyploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Filovirus entry into cells - new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Inclusion bodies are a site of ebolavirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Vesicular release of ebola virus matrix protein VP40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Ebola virus VP40-induced particle formation and association with the lipid bilayer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Possible leap ahead in filovirus therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

21 January 2018

Current ebola vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Establishment and application of an infectious virus-like particle system for Marburg virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

An upstream open reading frame modulates ebola virus polymerase translation and virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Ebola virus VP40 late domains are not essential for viral replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

RNA polymerase I-driven minigenome system for Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Generation of biologically contained Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

DNA topoisomerase 1 facilitates the transcription and replication of the Ebola virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Replication-deficient ebolavirus as a vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Development and application of reporter-expressing mononegaviruses: current challenges and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Shedding light on filovirus infection with high-content imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Development of high-content imaging assays for lethal viral pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Prospects for immunisation against Marburg and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

In Silico Derived Small Molecules Bind the Filovirus VP35 Protein and Inhibit Its Polymerase Cofactor Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Development of RNA Aptamers Targeting Ebola Virus VP35

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Identification of an antioxidant small-molecule with broad-spectrum antiviral activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

A systematic screen of FDA-approved drugs for inhibitors of biological threat agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Antiviral activity of a small-molecule inhibitor of filovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

Development of a broad-spectrum antiviral with activity against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.948848

10.1586/14787210.2014.948848

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference